Low impact
Chinese A-share pharmaceutical sector rallied, with Sairon Biotech surging over 10% and multiple peers including Sansheng Guojian, Tainuo Maibo, Aidi Pharma, Sanyuan Gene, Junshi Bio, Oulin Bio, Rejing Bio, and Frontier Bio gaining.
Jin1007/31, 08:44 AM
Related assets
Coming up for XSHE
Explore next
Latest XSHE news
FirstSquawk08/13, 03:12 PM
FirstSquawk08/06, 12:20 PM
Insurance and bank stocks decline amid concerns over a China tax crackdown.
Jin1008/05, 01:29 PM